Senores Pharma Reports Record Q2 Revenue and EBITDA
Senores Pharmaceuticals reported its highest-ever quarterly revenue and EBITDA in Q2 FY27, marking its ninth quarter of double-digit growth.
Senores Pharmaceuticals reported its highest-ever quarterly revenue and EBITDA in Q2 FY27, marking its ninth quarter of double-digit growth.